G7 urges donation of excess COVID vaccine to global sharing plan Coronavirus pandemic news

[ad_1]

UNICEF said that this move will solve the gap after India delayed planned exports in order to resist the outbreak of its own epidemic.

The head of UNICEF, the head of UNICEF, has asked G7 member countries to donate oversupply of COVID-19 vaccine to the global COVAX sharing program as an emergency measure to solve the serious shortage after India’s export restrictions.

India has promised COVAX to provide the AstraZeneca vaccine produced by its Serum Institute, but Family cases surge Restricted exports.

UNICEF, which is responsible for supplying coronavirus vaccines through COVAX, estimates that the supply shortage will reach 140 million doses by the end of May and 190 million doses by the end of June.

UNICEF Executive Director Henrietta Fore (Henrietta Fore) said on Monday: “The immediate sharing of available overdose is a minimum, necessary and urgent emergency measure that is needed now.” He added that this might be possible. Help prevent fragile countries from becoming the next global hot spot.

The leaders of the Group of Seven are scheduled to meet in the UK next month. The United States and Canada are both members of this organization, Authorized vaccine for people 12 years and older In recent weeks.

Last week, the head of the World Health Organization (WHO) condemned the “moral disaster” of vaccine inequality and urged rich countries Donate a dose instead of for children People who are less susceptible to serious diseases.

The UNICEF foreword quoted the latest research results of scientific information and analysis company Airfinity, saying that if the G7 member countries share only 20% of their available supply in June, July and August, they can donate about 153 million. Agent.

She said that this can be done while still fulfilling the promise of vaccinating her own population, she did not elaborate.

COVAX, jointly operated by the WHO and the GAVI Vaccine Alliance, relies heavily on AstraZeneca injections. AstraZeneca injections account for most of the vaccines designated for early launch of the 2 billion doses of vaccines to be launched this year.

UNICEF stated that other manufacturing restrictions outside of India have also slowed the supply of COVAX doses, but these delays are expected to be resolved by the end of June.



[ad_2]

Source link